Cita APA (7a ed.)

Canadian Agency for Drugs and Technologies in Health. (2017). Pharmacoeconomic Review Report: Ocrelizumab (Ocrevus) (Hoffmann-La Roche Limited). Canadian Agency for Drugs and Technologies in Health.

Cita Chicago Style (17a ed.)

Canadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Ocrelizumab (Ocrevus) (Hoffmann-La Roche Limited). Calgary, AB, CA: Canadian Agency for Drugs and Technologies in Health, 2017.

Cita MLA (9a ed.)

Canadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Ocrelizumab (Ocrevus) (Hoffmann-La Roche Limited). Canadian Agency for Drugs and Technologies in Health, 2017.